https://www.thefocalpoints.com/p/breaking-largest-human-cancer-study?utm_source=cross-post&publication_id=1119676&post_id=199616174&utm_campaign=564297&isFreemail=true&r=ccrm2&triedRedirect=true&utm_medium=email
https://www.thefocalpoints.com/p/breaking-largest-human-cancer-study?utm_source=cross-post&publication_id=1119676&post_id=199616174&utm_campaign=564297&isFreemail=true&r=ccrm2&triedRedirect=true&utm_medium=email
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a Major Cancer Journal
www.thefocalpoints.com
84.4% of cancer patients taking ivermectin + mebendazole for 6 months reported either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
0 Комментарии ·0 Поделились ·53 Просмотры ·0 предпросмотр